RKDA Arcadia Biosciences, Inc.
Nasdaq · SEC CIK 1469443 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 45 since 2021-07-13, latest 2026-09-14 16:03
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 9
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-05 | 2025-02-03 | RKDA | Schaefer Thomas J. | CEO | P - Purchase | $2.49 | +700 | 2,819 | +33% | +$1,743 | |
| 2025-02-05 | 2025-02-03 | RKDA | Kawakami Mark | CFO | P - Purchase | $2.49 | +700 | 2,681 | +35% | +$1,743 | |
| 2024-08-20 | 2024-08-01 | RKDA | Schaefer Thomas J. | CEO | P - Purchase | $2.06 | +700 | 2,119 | +49% | +$1,442 | |
| 2024-08-20 | 2024-08-01 | RKDA | Kawakami Mark | CFO | P - Purchase | $2.06 | +700 | 1,981 | +55% | +$1,442 | |
| 2024-02-05 | 2024-02-01 | RKDA | Schaefer Thomas J. | CFO | P - Purchase | $2.06 | +700 | 1,419 | +97% | +$1,442 | |
| 2023-08-07 | 2023-08-04 | RKDA | Schaefer Thomas J. | CFO | P - Purchase | $3.67 | +649 | 719 | +927% | +$2,382 | |
| 2023-05-30 | 2023-05-30 | RKDA | Jacot Stanley Jr | CEO | P - Purchase | $4.31 | +5,000 | 5,000 | New | +$21.5K | |
| 2023-02-02 | 2023-02-01 | RKDA | Schaefer Thomas J. | CFO | P - Purchase | $0.23 | +700 | 2,800 | +33% | +$161 | |
| 2022-08-03 | 2022-08-01 | RKDA | Haley Pamela | CFO | P - Purchase | $0.7 | +700 | 5,088 | +16% | +$490.00 |
Purchase Sale Sale after option exercise All abbreviations